Answers are grounded in this paper and cite their sources.
Background Caries and periodontitis are the most prevalent dental diseases in Germany, with children often affected on chewing surfaces and adolescents in interdental spaces. Both diseases can lead to tooth loss over time, making preventive measures crucial. Objectives Disease manifestation varies among patients due to factors such as diet, oral hygiene, and genetics. While poor oral hygiene is a well-established risk factor, genetic predispositions may also influence susceptibility to dental caries and periodontitis, but evidence in population-based cohorts is limited. This study aims to investigate the association between candidate gene polymorphisms (including AQP5 A(-1364)C) and oral disease severity, providing insights into how genetic factors contribute to inter-individual differences in oral health. Methods This research aims to identify genetic profiles associated with caries and periodontitis by examining candidate gene expression in saliva samples from dental patients and oral cancer patients. Aquaporin 5 (AQP5) is of interest, as AQP5-deficient mice have higher caries rates, indicating its potential protective role. A specific SNP in AQP5’s promoter region (A(-1364)C, rs3759129) reduces AQP5 expression in C-allele carriers and was associated with improved survival in severe sepsis, suggesting a broader biological impact. This study will investigate if this SNP correlates with caries and periodontitis. Additionally, genes linked to tooth formation (e.g., ENAM, AMELX), saliva production (CA6), and inflammation (TIMP1, TNF) will be examined for their roles in disease susceptibility, potentially advancing individualized prevention and treatment. Ethics The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of the medical faculty of the Ruhr University Bochum (23-7821-BR, date of approval: 07.06.2023), Ethics committee of the Westphalia-Lippe Medical Association (2024-299-f-S date of approval 01.07.2023). Trial registration The study is registered in the German Clinical Trials Register (DRKS) DRKS-ID: DRKS00032425.
No takes yet. Share an insight, caveat, or question.
Pakosch-Nowak et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: